Fitness to Practise Cases
This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.
Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:
- Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
- Employers & HR Teams – to learn about professional accountability and compliance.
- Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.
Why it matters:
The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.
Use the form below to search for and filter cases that match your interests
Page 8 of 54
Pharmacist Suspended After Dishonest Independent Prescribing Course Applications and MEDLRN Website Concerns
Allegations This case centred on the registrant’s activities through MEDLRN Limited, a company which offered educational and support services to pharmacists pursuing Independent Prescribing qualifications. The concerns arose in two main contexts: the University of Manchester Independent Prescribing course and the University of Wolverhampton Independent Prescribing course. In relation to the University of Manchester, the […]
22 May 2026
GPhC Suspends Two Pharmacists and Removes Superintendent Over Unsafe Online Prescribing of High-Risk Medicines
Allegations This substantial GPhC Fitness to Practise case examined the operation of Homecare Pharmacy, a distance-selling pharmacy linked to two online prescribing services: UK Meds and MyUKDoctor. The proceedings involved three experienced pharmacists who held senior professional responsibilities within the business, including Responsible Pharmacist and Superintendent Pharmacist roles. The central concern was whether the pharmacists […]
18 May 2026
Pharmacist Issued GPhC Warning After Taking Diazepam and Omeprazole From Pharmacy Stock During Shifts Amid Personal and Health Difficulties
Allegations This case concerned a pharmacist who admitted taking prescription-only medicines, including Diazepam and Omeprazole, from pharmacy stock whilst acting as the Responsible Pharmacist at a community pharmacy in Hampshire. The conduct occurred during May and June 2023 and was identified after the superintendent pharmacist reviewed CCTV footage due to concerns about the registrant’s punctuality […]
14 May 2026
Pharmacist Suspension Ends After Dishonesty Findings Involving Dispensing Error, Complan Consumption and Use of Returned Prednisolone for Pet Dog
Allegations This case concerned a pharmacist with a long professional career of approximately 38 years who appeared before the General Pharmaceutical Council Fitness to Practise Committee for a review of a suspension order originally imposed in February 2019. The underlying misconduct stemmed from several incidents in 2016 involving dishonesty, poor professional judgment, failure to follow […]
13 May 2026
Pharmacist Issued Warning After Unauthorised Access to Patient Records via Shared Prescriber Login
Allegations This case concerns a superintendent pharmacist who accessed confidential patient information through an online prescribing platform (eRoseway) using login credentials that were not assigned to him. The registrant worked at a private compounding pharmacy producing hormone medications, where prescribing workflows often involved digital platforms. The system in question, operated by Roseway Labs, allowed prescribers […]
2 May 2026
Boots Pharmacist Suspension Extended After Codeine Theft, Self-Dispensing and Failure to Report Police Caution
Allegations This was a principal review hearing concerning a pharmacist whose original suspension order was under review on 20 April 2026. The underlying case was serious and involved both misconduct and a police caution. The proved allegations showed that, while signed off sick, the registrant attended the pharmacy without authority, accessed the Columbus pharmacy information […]
21 April 2026
NI Pharmacist Struck Off After 25,000 Diazepam Tablets Went Missing Over Three Years
Allegations This case concerned a pharmacist who, over a prolonged period from 1 January 2021 to 21 March 2024, unlawfully obtained diazepam from the community pharmacy where the registrant worked as both pharmacist and pharmacy practice manager. The registrant also routinely acted as the Responsible Pharmacist for the premises. The case arose after anomalies were […]
GPhC review: Pharmacist who issued illegitimate Covid-19 Fit to Fly certificates allowed back under strict conditions
Allegations This was a principal review hearing following earlier substantive and review proceedings. The case arose from the registrant’s conduct in connection with Covid-19 testing services offered through the pharmacy. The proved allegations were serious and multifaceted. They included the placing of a used Covid-19 swab back into its packaging, failures to keep records of […]
17 April 2026
Suspended NI pharmacist allowed return under strict conditions after review hearing finds insight and remediation developing
Allegations: This case was a review hearing, so the main issue was not whether the original allegations were proved, but whether the registrant had done enough since the previous suspension to address the concerns. The original case involved serious misconduct by an experienced pharmacist and independent prescriber. The registrant had admitted dishonesty, lack of integrity, […]
15 April 2026
Pharmacy Technician Struck Off After Cocaine Misconduct and Class A Drug Conviction
Allegations This GPhC principal review hearing concerned a pharmacy technician whose fitness to practise had previously been found impaired following misconduct involving cocaine use and a criminal conviction for possession of a Class A drug. The allegations arose from events while the registrant was employed at St Pancras Hospital. The original findings, all proved, were […]
14 April 2026